Clinical trials with haemopoietic growth factors

Progress in Growth Factor Research
W P Steward, J H Scarffe

Abstract

Five glycoprotein growth factors capable of stimulating the proliferation and differentiation of haemopoietic progenitor cells in vitro have been identified and sequenced over the past ten years. Recombinant DNA technology has recently enabled the production of sufficient amounts of these agents for preclinical testing. Erythropoietin (EPO), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) have already entered clinical studies in humans. Interleukin-3 (IL-3) and macrophage colony-stimulating factor (M-CSF) should soon be available for use in humans. EPO corrects the anaemia of end stage renal failure, improving the quality of life for such patients and preventing the need for red cell transfusions. At high dose it increases platelet production in vitro and in vivo and may be of value in humans to prevent the thrombocytopaenia associated with chemotherapy. G-CSF and GM-CSF have been used in several clinical studies. Administration of both growth factors results in a leucocytosis, G-CSF predominantly increasing neutrophil production and GM-CSF increasing production of neutrophils, eosinophils and monocytes. The optimal administration of these agents is via continuous int...Continue Reading

References

Jan 15, 1987·International Journal of Cancer. Journal International Du Cancer·C G BegleyN A Nicola
Jan 1, 1986·Cold Spring Harbor Symposia on Quantitative Biology·R E DonahueG Shaw
Jun 1, 1982·Journal of Cellular Physiology·D Metcalf, A W Burgess
Aug 15, 1982·International Journal of Cancer. Journal International Du Cancer·D Metcalf
Dec 15, 1982·International Journal of Cancer. Journal International Du Cancer·D Metcalf, N A Nicola

❮ Previous
Next ❯

Citations

Jan 1, 1990·International Journal of Cell Cloning·M AgliettaF Gavosto
Sep 1, 1992·International Journal of Cell Cloning·G J Spangrude
Nov 1, 1992·Pharmacology & Therapeutics·J M Siegfried
Jun 1, 1989·Current Opinion in Immunology·V MalkovskaM Malkovský
Aug 1, 1994·British Journal of Haematology·S KemahliA Arcasoy
Jun 1, 1991·Journal of the American Academy of Dermatology·T A Luger, T Schwarz
Sep 1, 1989·Trends in Endocrinology and Metabolism : TEM·L E Underwood
Mar 1, 1990·Clinical Immunology and Immunopathology·R L MonroyT J MacVittie
Mar 23, 2018·Parasitology·Miles B Markus
Jun 24, 2017·Heart Failure Reviews·Hemalatha ThiagarajanAnbukkarasi Kaliyaperumal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.